Startseite Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone

  • Kelli K. Ryckman EMAIL logo , Cassandra N. Spracklen , John M. Dagle und Jeffrey C. Murray
Veröffentlicht/Copyright: 22. Mai 2014
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Journal of Pediatric Endocrinology and Metabolism Band 27 Heft 9-10

Abstract

Thyroid hormones are important regulators of fetal neurodevelopment. Among preterm infants, thyroid stimulating hormone (TSH) is highly variable. Understanding this variability will further improvements in screening for thyroid disorders in preterm infants. We examined 61 maternal and infant clinical and demographic factors for associations with neonatal TSH levels in 698 preterm neonates. TSH was measured as part of routine State-mandated newborn screening in Iowa. Of the maternal characteristics, nulliparous women (p=8×10–4), women with preeclampsia (p=2×10–3), and those with induced labor (p=3×10–3) had infants with higher TSH levels. TSH levels at the time of newborn screening were associated with respiratory distress syndrome (RDS) (p<0.0001) and sepsis (p=3×10–3). We replicated findings between parity and preeclampsia previously observed in primarily term infants. We also observed strong relationships between neonatal TSH and complications of prematurity including RDS and sepsis, which have implications for future studies examining this relationship both prenatally and longitudinally after birth.

Keywords: pregnancy complications; preterm birth; respiratory distress and sepsis; thyroid stimulating hormone (TSH)
Corresponding author: Kelli K. Ryckman, PhD, Assistant Professor, Department of Epidemiology, College of Public Health, University of Iowa, 105 River St, S414 CPHB, Iowa City, IA 52242, USA, Phone: +319-384-1546, E-mail:

Acknowledgments

We would like to express our thanks to all the participating families in our study. We would also like to express our gratitude to the coordinating medical and research staff at the University of Iowa Hospitals and Clinics in Iowa City, IA, USA; including a special thanks to research coordinators Laura Knosp and Susan Berends. We would also like to thank Franklin Delin, Dariush Shirazi, and Stanton Berberich from the State Hygienic Laboratory for their assistance in the acquisition of the newborn screening data.

Conflict of interest statement

Authors Disclosure Statement: No competing financial interests exist.

Financial Statement: This work was supported by the March of Dimes (1-FY05-126 and 6-FY08-260), National Institutes of Health, and Eunice Kennedy Shriver National Institute of Child Health & Human Development (R01 HD-52953, R01 HD-57192, and R00 HD-065786). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.

References

1. Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SM, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study. J Clin Endocrinol Metab 2012;97:646–52.10.1210/jc.2011-2398Suche in Google Scholar PubMed

2. Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol 2012;119:315–20.10.1097/AOG.0b013e318240de6aSuche in Google Scholar PubMed

3. Schneuer FJ, Nassar N, Tasevski V, Morris JM, Roberts CL. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab 2012;97:3115–22.10.1210/jc.2012-1193Suche in Google Scholar PubMed

4. Ryckman KK, Berberich SL, Shchelochkov OA, Cook DE, Murray JC. Clinical and environmental influences on metabolic biomarkers collected for newborn screening. Clin Biochem 2013;46:133–8.10.1016/j.clinbiochem.2012.09.013Suche in Google Scholar PubMed PubMed Central

5. Alul FY, Cook DE, Shchelochkov OA, Fleener LG, Berberich SL, et al. The heritability of metabolic profiles in newborn twins. Heredity (Edinb) 2013;110:253–8.10.1038/hdy.2012.75Suche in Google Scholar PubMed PubMed Central

6. Tanaka K, Shimizu T, Hosaka A, Tokita A, Shiga S, et al. Serum free T4 and thyroid stimulating hormone levels in preterm infants and relationship between these levels and respiratory distress syndrome. Pediatr Int 2007;49:447–51.10.1111/j.1442-200X.2007.02390.xSuche in Google Scholar PubMed

7. Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR. Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 2008;18:67–76.10.1089/thy.2007.0180Suche in Google Scholar PubMed

8. Wilker RE, Fleischman AR, Saenger P, Pan C, Surks MI. Thyroid hormone levels in diabetic mothers and their neonates. Am J Perinatol 1984;1:259–62.10.1055/s-2007-1000015Suche in Google Scholar PubMed

9. Ward LS, Kunii IS, de Barros Maciel RM. Thyroid stimulating hormone levels in cord blood are not influenced by non-thyroidal mothers’ diseases. Sao Paulo Med J 2000;118:144–7.10.1590/S1516-31802000000500006Suche in Google Scholar

10. Sullivan KM, May W, Nordenberg D, Houston R, Maberly GF. Use of thyroid stimulating hormone testing in newborns to identify iodine deficiency. J Nutr 1997;127:55–8.10.1093/jn/127.1.55Suche in Google Scholar PubMed

11. Franklin R, O’Grady C, Carpenter L. Neonatal thyroid function: comparison between breast-fed and bottle-fed infants. J Pediatr 1985;106:124–6.10.1016/S0022-3476(85)80481-9Suche in Google Scholar

12. Chan LY, Chiu PY, Lau TK. Cord blood thyroid-stimulating hormone level in high-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;108:142–5.10.1016/S0301-2115(02)00418-9Suche in Google Scholar

13. Lao TT, Lee CP. Gestational diabetes mellitus and neonatal hyperthyrotropinemia. Gynecol Obstet Invest 2002;53:135–9.10.1159/000058363Suche in Google Scholar

14. Hitchcock KR. Lung development and the pulmonary surfactant system: hormonal influences. Anat Rec 1980;198:13–34.10.1002/ar.1091980103Suche in Google Scholar

15. Hitchcock KR. Hormones and the lung. I. Thyroid hormones and glucocorticoids in lung development. Anat Rec 1979;194:15–39.10.1002/ar.1091940103Suche in Google Scholar

16. Wilson M, Hitchcock KR, Douglas WH, DeLellis RA. Hormones and the lung. II. Immunohistochemical localization of thyroid hormone binding in type II pulmonary epithelial cells clonally-derived from adult rat lung. Anat Rec 1979;195:611–9.10.1002/ar.1091950404Suche in Google Scholar

17. van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 1997;42:604–9.10.1203/00006450-199711000-00009Suche in Google Scholar

18. Klein RZ, Carlton EL, Faix JD, Frank JE, Hermos RJ, et al. Thyroid function in very low birth weight infants. Clin Endocrinol (Oxf) 1997;47:411–7.10.1046/j.1365-2265.1997.2511064.xSuche in Google Scholar

19. Cuestas RA, Lindall A, Engel RR. Low thyroid hormones and respiratory-distress syndrome of the newborn. Studies on cord blood. N Engl J Med 1976;295:297–302.10.1056/NEJM197608052950601Suche in Google Scholar

20. Cuestas RA, Engel RR. Thyroid function in preterm infants with respiratory distress syndrome. J Pediatr 1979;94:643–6.10.1016/S0022-3476(79)80042-6Suche in Google Scholar

21. Steffen KM, Cooper ME, Shi M, Caprau D, Simhan HN, et al. Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery. J Perinatol 2007;27:672–80.10.1038/sj.jp.7211806Suche in Google Scholar

22. Ehn NL, Cooper ME, Orr K, Shi M, Johnson MK, et al. Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth. Pediatr Res 2007;62:630–5.10.1203/PDR.0b013e3181567bfcSuche in Google Scholar

23. Simpson J, Williams FL, Delahunty C, van Toor H, Wu SY, et al. Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J Clin Endocrinol Metab 2005;90:1271–9.10.1210/jc.2004-2091Suche in Google Scholar

24. Ng SM, Wong SC, Paize F, Chakkarapani E, Newland P, et al. Multivariate analyses of factors that affect neonatal screening thyroid stimulating hormone. J Pediatr Endocrinol Metab 2011;24:727–32.Suche in Google Scholar

25. Korada M, Pearce MS, Avis E, Turner S, Cheetham T. TSH levels in relation to gestation, birth weight and sex. Horm Res 2009;72:120–3.10.1159/000232165Suche in Google Scholar

26. Dokumov SI, Milanov SC, Trepetshov SP. Thyroid-stimulating hormone in serum of mother and newborn at birth. J Obstet Gynaecol Br Commonw 1971;78:809–11.10.1111/j.1471-0528.1971.tb00343.xSuche in Google Scholar

27. Belet N, Imdat H, Yanik F, Kucukoduk S. Thyroid function tests in preterm infants born to preeclamptic mothers with placental insufficiency. J Pediatr Endocrinol Metab 2003;16:1131–5.10.1515/JPEM.2003.16.8.1131Suche in Google Scholar

28. Narin N, Kurtoglu S, Basbug M, Caksen H, Kafali M, et al. Thyroid function tests in the newborn infants of preeclamptic women. J Pediatr Endocrinol Metab 1999;12:69–73.10.1515/JPEM.1999.12.1.69Suche in Google Scholar

29. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, et al. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987;65:315–20.10.1210/jcem-65-2-315Suche in Google Scholar

30. Mitchell IM, Pollock JC, Jamieson MP, Donaghey SF, Paton RD, et al. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg 1992;103:800–5.10.1016/S0022-5223(19)34965-7Suche in Google Scholar

31. Murzi B, Iervasi G, Masini S, Moschetti R, Vanini V, et al. Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass. Ann Thorac Surg 1995;59:481–5.10.1016/0003-4975(94)00879-CSuche in Google Scholar

32. Van den Berghe G, de Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994;22:1747–53.10.1097/00003246-199422110-00008Suche in Google Scholar

33. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group. Am J Obstet Gynecol 1998;178:33–9.10.1016/S0002-9378(98)70622-2Suche in Google Scholar

34. Fisch RO, Bilek MK, Miller LD, Engel RR. Physical and mental status at 4 years of age of survivors of the respiratory distress syndrome. Follow-up report from the collaborative study. J Pediatr 1975;86:497–503.10.1016/S0022-3476(75)80137-5Suche in Google Scholar

35. Crump C, Winkleby MA, Sundquist J, Sundquist K. Preterm birth and risk of medically treated hypothyroidism in young adulthood. Clin Endocrinol (Oxf) 2011;75:255–60.10.1111/j.1365-2265.2011.04034.xSuche in Google Scholar PubMed PubMed Central

36. Yildizdas D, Onenli-Mungan N, Yapicioglu H, Topaloglu AK, Sertdemir Y, et al. Thyroid hormone levels and their relationship to survival in children with bacterial sepsis and septic shock. J Pediatr Endocrinol Metab 2004;17:1435–42.10.1515/JPEM.2004.17.10.1435Suche in Google Scholar

37. den Brinker M, Joosten KF, Visser TJ, Hop WC, de Rijke YB, et al. Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. J Clin Endocrinol Metab 2005;90:5613–20.10.1210/jc.2005-0888Suche in Google Scholar PubMed

38. den Brinker M, Dumas B, Visser TJ, Hop WC, Hazelzet JA, et al. Thyroid function and outcome in children who survived meningococcal septic shock. Intensive Care Med 2005;31:970–6.10.1007/s00134-005-2671-8Suche in Google Scholar PubMed

39. Das BK, Agarwal P, Agarwal JK, Mishra OP. Serum cortisol and thyroid hormone levels in neonates with sepsis. Indian J Pediatr 2002;69:663–5.10.1007/BF02722699Suche in Google Scholar PubMed

40. Williams F, Hume R. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem 2011;48:7–22.10.1258/acb.2010.010174Suche in Google Scholar PubMed

Received: 2013-9-10
Accepted: 2014-4-22
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0366
Schlagwörter für diesen Artikel
pregnancy complications; preterm birth; respiratory distress and sepsis; thyroid stimulating hormone (TSH)

Artikel in diesem Heft

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 27.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0366/html
Button zum nach oben scrollen